BRAF and colorectal carcinoma: Even though MSI is associated with BRAF mutation in CRC, 25–54% of BRAF mutant CRC cases are microsatellite stable (MSS), which is characterized by poorer survival compared to BRAF mutant-MSI CRC cases [22,23,24,25,26].